Transcutaneous Treatments of Hepatocellular Carcinoma in Patients with Cirrhosis: Present Status and Future Developments

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|32|3274-3278

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.32, 2007-11, pp. : 3274-3278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model

By  

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3485-3493

Blackwell Publishing

Access to resources Recommend Favorite

Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 54-60

Bentham Science Publishers

Access to resources Recommend Favorite

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 112-118

Bentham Science Publishers

Access to resources Recommend Favorite

Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 1, 2015-05 ,pp. : 54-60

Bentham Science Publishers

Access to resources Recommend Favorite

The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 112-118

Bentham Science Publishers

Access to resources Recommend Favorite